Case Report: Confirmed and suspected heparin-induced thrombocytopenia during therapeutic plasma exchange in neuromyelitis optica spectrum disorder: a single-centre case series. [PDF]
Podlecka-Piętowska A +4 more
europepmc +1 more source
Comparative effectiveness of parenteral anticoagulants (fondaparinux, argatroban, bivalirudin) in heparin-induced thrombocytopenia: A systematic review. [PDF]
Rehman A +11 more
europepmc +1 more source
Venous thromboembolism (VTE) is one of the leading causes of morbidity and mortality in acutely ill medical patients. Fondaparinux is recommended for the prevention of VTE in this setting, but little information is available on its safety and ...
Bergamo, M +12 more
core
Drugs to Prevent and Treat Venous Thromboembolic Disease During Pregnancy. [PDF]
James AH, Federspiel JJ.
europepmc +1 more source
Disproportionality analysis of fondaparinux associated adverse events based on the FDA adverse event reporting system. [PDF]
Kang F +6 more
europepmc +1 more source
Machine learning in bleeding risk assessment for low-molecular-weight heparin or fondaparinux: a predictive model study. [PDF]
Chen H, Ran Q, Hu F, Zheng X.
europepmc +1 more source
Adverse event profile of fondaparinux sodium: a disproportionality analysis based on FAERS, JADER, and VigiAccess databases. [PDF]
Jin W, Pan J, Yu L, Zhu M.
europepmc +1 more source
Anticoagulation for Cancer Patients in Special Situations: A Narrative Review of Guidelines and Literature. [PDF]
Sotoca Rubio P +12 more
europepmc +1 more source
Safety Profile and Bleeding Complications of Fondaparinux Versus Enoxaparin in Non-ST Elevation Acute Coronary Syndrome. [PDF]
Rahman MM +4 more
europepmc +1 more source

